Nuclivision
Ghent, BE · Founded 2022 · 19 employees on LinkedIn · 2 known investors
Find your way into Nuclivision
Sign up to find every way you can get introduced to Nuclivision
- Your email: who you already know at Nuclivision, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Nuclivision team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Nuclivision develops AI software to enhance nuclear medicine imaging, enabling PET centers to increase capacity and reduce costs without replacing equipment. The platform serves clinical departments across Europe and the US.
Founders & leadership
Nuclivision was founded in 2022 by Maarten Larmuseau, Tomas Brants, and Simon DeKeyser.
Investors · 2
Funding
SEC filings, press & company announcements$5.5M disclosed across 1 round · 2025
- $5.5MraisedApr 2025 · 2 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Nuclivision do?
- Nuclivision develops AI software to enhance nuclear medicine imaging, enabling PET centers to increase capacity and reduce costs without replacing equipment. The platform serves clinical departments across Europe and the US.
- Who founded Nuclivision?
- Nuclivision was founded by Maarten Larmuseau, Tomas Brants, Simon DeKeyser in 2022.
- Who are Nuclivision's investors?
- Nuclivision's investors include Heran Partners, imec.istart.
- How much funding has Nuclivision raised?
- Nuclivision has disclosed $5.5M raised across 1 round.
- Where is Nuclivision headquartered?
- Nuclivision is headquartered in Ghent, BE.



